A Step-by-Step Guide to Studying Pneumonia-Induced Heart Damage in Space

Introduction

Did you know that the bacteria causing pneumonia, Streptococcus pneumoniae, can also wreak havoc on your heart? Even after the infection clears, survivors face a higher risk of heart disease. To unravel this connection, researchers are taking the fight to space—literally. Aboard the International Space Station (ISS), scientists are infecting lab-grown heart tissues with pneumonia bacteria in microgravity. Why? Because in space, bacteria become more aggressive, making subtle heart cell responses easier to detect. This how-to guide explains the steps researchers follow to conduct this groundbreaking study, from preparing samples on Earth to analyzing results that could protect hearts both here and in deep space.

A Step-by-Step Guide to Studying Pneumonia-Induced Heart Damage in Space — Source: www.nasa.gov

What You Need

Stem cell-derived heart tissue models (also called cardiac organoids or engineered heart tissues)
Live Streptococcus pneumoniae bacteria (clinical isolates from community-acquired pneumonia)
MVP Cell-09 hardware (a portable glovebag for sterile handling)
ISS microgravity environment (or a simulated microgravity setup for ground controls)
Ground control equipment (identical hardware in 1G for comparison)
Bioreactors or culture flasks for pre-flight growth of tissues
Transport containers that maintain temperature and humidity during launch
Research team: astronauts to operate experiments, and ground scientists to analyze data
Imaging and molecular analysis tools (e.g., confocal microscopy, qPCR, RNA sequencing)

Step-by-Step Instructions

Step 1: Engineer Heart Tissue Models on Earth

Start by growing human induced pluripotent stem cells and differentiating them into cardiomyocytes (heart muscle cells). Then, coax these cells into forming three-dimensional structures that mimic real heart tissue. This step takes several weeks and requires precise control of nutrients, oxygen, and growth factors. The final product is a set of mini-hearts that can beat and respond to infection.

Step 2: Prepare the Bacteria

Meanwhile, culture Streptococcus pneumoniae under controlled conditions. Because the bacteria will be handled in space, they must be in a secure, double-contained container. A small, pre-measured dose—enough to infect the heart tissues later—is loaded into a syringe-like device that can be attached to the glovebag.

Step 3: Load the MVP Cell-09 Hardware

The MVP Cell-09 is a portable glovebag designed for sterile cell and microbiology experiments on the ISS. Before launch, technicians insert the heart tissue models and the bacterial inoculum into separate compartments inside the glovebag. The whole assembly is then placed in a temperature-controlled transport box and sent to the space station aboard a resupply mission.

Step 4: Set Up the Experiment in Microgravity

Once the hardware reaches the ISS, an astronaut (like Jack Hathaway or Sophie Adenot) transfers it into the glovebag. She attaches the glovebag to a workstation and creates a sealed, sterile environment. Inside, the heart tissue models are placed in a culture chamber while the bacterial syringe is kept separate until the infection step.

Step 5: Infect the Heart Tissues

The astronaut injects the bacteria into the chamber containing the heart tissues. In microgravity, the bacterial cells distribute differently than on Earth—they don't settle to the bottom, so they interact with more of the heart cell surface. This enhanced contact mimics what might happen in the lungs during severe pneumonia, but now in a controlled dish.

Step 6: Monitor the Response in Real Time

Over the next hours and days, the heart tissues are observed using built-in cameras and sensors. Astronauts note changes in beating rate, tissue contraction strength, and any visible damage. For comparison, an identical set of tissues remains uninfected as a control. All data is transmitted to the ground team in near-real time.

Step 7: Preserve Samples for Return to Earth

After several days of infection (typically 3-7 days), the astronaut fixes the tissues with a preservative or freezes them at -80°C. These samples are packed into a return capsule and shipped back to Earth on a SpaceX Dragon or similar vehicle.

Step 8: Conduct Advanced Analysis on the Ground

Back at the University of Alabama at Birmingham, Dr. Palaniappan Sethu and Dr. Carlos Orihuela’s teams perform deep molecular analyses. They look for changes in gene expression, protein production, and cellular structure. Key questions include: Which heart cell pathways are disrupted? Does the bacteria trigger inflammation that leads to fibrosis? And crucially, are the same changes seen in space also present in ground controls, just milder?

Step 9: Compare Space vs. Earth Results

By comparing the space data with control experiments done at 1G (normal gravity), researchers can isolate which effects are amplified by microgravity. This comparison is critical because on Earth, the bacterial infection might not produce a strong enough signal to detect subtle heart damage. In space, the “exaggerated” infection makes the differences obvious, revealing new drug targets or biomarkers.

Tips for Success

Start simple. If you're new to space biology, work with established cell lines before attempting stem cell derivatives.
Use multiple controls. Ground controls should simulate temperature, vibration, and timing exactly as in space to isolate gravity’s effect.
Collaborate widely. This research brings together mechanical engineers, microbiologists, cardiologists, and astronauts—each skill is vital.
Plan for failure. Hardware delays and launch anomalies happen. Have backup samples and flexible timelines.
Focus on translational impact. Always tie observations back to human health on Earth and long-duration space exploration.

By following these steps, researchers can unlock how pneumonia bacteria damage the heart—and how to prevent that damage in astronauts and Earth patients alike. The ISS provides a unique platform to accelerate discovery, but the real payoff comes when these insights lead to new therapies for the millions affected by community-acquired pneumonia each year.

Tags: